CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...